Harrison Dean M Reports Recent Stock Transactions
Harrison Dean M discloses stock transactions, reflecting his commitment to Northern Trust Corp, potentially impacting investor sentiment in the banking sector.
Sukhatme Mayukh reports stock transaction of 46,879 shares
Sukhatme Mayukh, President and CIO of Roivant Sciences, reports a significant stock transaction of 46,879 shares, reflecting changes in executive ownership.
Hexter Joshua sells 30,000 shares of Oramed Pharmaceuticals
Hexter Joshua sold 30,000 shares of Oramed Pharmaceuticals, reflecting strategic investment decisions within the pharmaceutical sector.
Picon Juan reports stock transactions as Honeywell CEO
Picon Juan, CEO of BA, files stock transactions, reflecting ongoing compensation strategies at Honeywell International Inc. Learn more about the implications.
Grieco acquires over 2 million shares of Innventure, Inc.
Grieco William J. has acquired over 2 million shares of Innventure, Inc., signaling confidence in the company's future as its CEO.
Donnally James O Reports Stock Transactions for Innventure, Inc.
Donnally James O files a Form 4 detailing stock transactions for Innventure, Inc., reflecting strategic asset management in the blank checks industry.
McCarthy Cornelius P. III Reports Stock Transactions at Medpace
Cornelius P. McCarthy III disclosed stock transactions involving common and restricted stock units at Medpace Holdings, Inc., highlighting ongoing equity management.
Hohmann Neil Martin Reports Class S Units Transaction
Hohmann Neil Martin discloses a transaction involving Class S units of AMG BBH Asset-Backed Credit Fund, LLC, reflecting ongoing investment activities.
Gabay Avraham sells 20,000 shares of Oramed Pharmaceuticals
Gabay Avraham reports the sale of 20,000 shares of Oramed Pharmaceuticals, revealing strategic financial actions in the pharmaceutical sector.
Maximus General Counsel Reports Stock Transaction
Elizabeth Moellering of Maximus, Inc. reports stock transaction, surrendering shares to cover tax obligations related to restricted stock units.
Maximus Principal Accounting Officer Surrenders Shares for Tax
Theresa D. Golinvaux of Maximus, Inc. surrenders shares to cover tax obligations, reflecting compliance with regulatory requirements.
Sengstack Reports Share Transactions for Franklin Electric Co.
Gregg C. Sengstack discloses share transactions for Franklin Electric Co., indicating ongoing investment activity and potential implications for the motors and generators industry.
Maurer Carlos A. reports stock transaction for ARKO Petroleum
Maurer Carlos A. has reported a stock transaction involving ARKO Petroleum Corp., reflecting ongoing equity management and corporate governance.
CFO Michael Brian Bell Reports Stock Transactions at Guardant
Michael Brian Bell, CFO of Guardant Health, discloses stock transactions, reflecting his financial engagement with the company. Details inside.
Quaggin Susan E acquires stock equivalent units at AbbVie
Quaggin Susan E, director at AbbVie, acquires 59 stock equivalent units, signaling confidence in the company's future.
Mendola Reports Preferred Shares Transaction in Leef Brands
Robert James Mendola Jr. reports a transaction involving 1,224 Series A1 Preferred Shares of Leef Brands Inc., highlighting changes in ownership.
Joshi Aman sells 8,437 shares of Bloom Energy stock
Joshi Aman, Chief Commercial Officer of Bloom Energy, sold 8,437 shares of stock as part of a trading plan, reflecting ongoing executive trading activity.
ARKO Petroleum grants restricted stock units to director
ARKO Petroleum Corp. reports a grant of restricted stock units to a director, highlighting its commitment to talent retention in the competitive wholesale petroleum industry.
Mutryn Surrenders Shares to Cover Tax Obligations
David Mutryn, CFO of Maximus, Inc., surrenders shares to cover tax obligations, reflecting ongoing equity management within the company.
AbbVie director Edward J. Rapp acquires stock equivalent units
AbbVie Inc. director Edward J. Rapp reported acquiring stock equivalent units, reflecting the company's compensation strategies in the pharmaceutical sector.